Opinions Ted Macklin
Nordion IncNDN.TOWAITOct 30, 2003
Proteomics is executing their well in a difficult environment. The US lab business has not done well and expects they will sell it. Still frustrated that there are no concrete numbers that he can't hold them accountable to. Have to see more visibility
Ted MacklinUnknown
$19.94
Stock price when the opinion was issued
other services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
